Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.62 - $2.85 $22,680 - $39,900
14,000 Added 24.14%
72,000 $119,000
Q1 2024

May 06, 2024

BUY
$1.6 - $2.48 $92,800 - $143,840
58,000 New
58,000 $143,000
Q1 2023

May 11, 2023

BUY
$2.36 - $3.35 $18,880 - $26,800
8,000 New
8,000 $20,000
Q2 2022

Aug 10, 2022

BUY
$3.11 - $7.48 $44,093 - $106,051
14,178 Added 64445.45%
14,200 $3,000
Q1 2022

May 12, 2022

SELL
$4.88 - $8.56 $2,332 - $4,091
-478 Reduced 95.6%
22 $4,000
Q2 2021

Aug 06, 2021

BUY
$13.68 - $22.34 $6,840 - $11,170
500 New
500 $0
Q1 2020

May 21, 2020

SELL
$2.47 - $21.36 $7,410 - $64,080
-3,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$15.72 - $24.88 $47,160 - $74,640
3,000 New
3,000 $4,000

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $942M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.